EURO STOXX 50 Index Ends the Week 4.02% Higher at 5067.45 — Data Talk
The EURO STOXX 50 Index is up 195.91 points or 4.02% this week to 5067.45
--Largest one week point gain since the week ending Jan. 6, 2023
--Largest one week percentage gain since the week ending Jan. 26, 2024
--Up for three consecutive weeks
--Up 329.39 points or 6.95% over the last three weeks
--Largest three week point gain since the week ending Jan. 13, 2023
--Largest three week percentage gain since the week ending Nov. 17, 2023
--Up seven of the past eight weeks
--Today it is up 34.86 points or 0.69%
--Up for two consecutive trading days
--Up 150.56 points or 3.06% over the last two trading days
--Largest two day point gain since Tuesday, Oct. 4, 2022
--Largest two day percentage gain since Friday, Nov. 11, 2022
--Up four of the past five trading days
--Off 7.26% from its record close of 5464.43 hit Monday, March 6, 2000
--Highest closing value since Thursday, June 6, 2024
--Off 0.66% from its 52-week high of 5100.90 hit Wednesday, May 15, 2024
--Up 26.23% from its 52-week low of 4014.36 hit Friday, Oct. 27, 2023
--Rose 21.39% from 52 weeks ago
--Off 0.66% from its 2024 closing high of 5100.90 hit Wednesday, May 15, 2024
--Up 15.09% from its 2024 closing low of 4403.08 hit Wednesday, Jan. 17, 2024
--Month-to-date it is up 2.21%
--Year-to-date it is up 545.80 points or 12.07%
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 27, 2024 12:41 ET (16:41 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks